The Paneth cells could become a target for treatments, according to researchers from the University of Cambridge and Harvard University. The discovery of the role they play in intestinal inflammation could open the door for an entirely new approach to Crohn’s disease therapies.
More Articles on Gastroenterology:
RedHill Biopharma Seeks Patients for Phase III Crohn’s Disease Treatment Drug Trial
Kanawha Valley Gastroenterology Associates Selects Benchmark Systems EHR
Dr. Gurpreet Singh Joins Woodland Healthcare in California
